Stock 300452 ANHUI SUNHERE PHARMACEUTICAL EXCIPIENTS CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.

Equities

300452

CNE100001ZH5

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 14/05/2024 BST 		5-day change 1st Jan Change
13.14 CNY -2.95% Intraday chart for Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. -3.17% -7.72%
04-26 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Proposes Final Cash Dividend for 2023 CI
04-25 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025
Capitalization 1 3,916 4,071 3,308 3,052 -
Enterprise Value (EV) 1 3,916 4,071 3,308 3,052 3,052
P/E ratio 44.7 x 31.3 x 21.3 x 16.4 x 13.8 x
Yield - - - - -
Capitalization / Revenue - 5.78 x 3.94 x 3.16 x 2.72 x
EV / Revenue - 5.78 x 3.94 x 3.16 x 2.72 x
EV / EBITDA - 23.6 x 14.7 x 11 x 9.11 x
EV / FCF - - - - -
FCF Yield - - - - -
Price to Book - 5.69 x 4.02 x 3.19 x 2.7 x
Nbr of stocks (in thousands) 232,471 232,387 232,324 232,304 -
Reference price 2 16.85 17.52 14.24 13.14 13.14
Announcement Date 22/04/22 07/04/23 25/04/24 - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023 2024 2025
Net sales 1 - 704.5 839.3 967 1,122
EBITDA 1 - 172.5 224.5 277 335
EBIT 1 - 136.3 185.4 213 253
Operating Margin - 19.34% 22.1% 22.03% 22.55%
Earnings before Tax (EBT) 1 - 136.4 185.8 213 253
Net income 1 89.25 130.7 161.5 187 222
Net margin - 18.55% 19.25% 19.34% 19.79%
EPS 2 0.3769 0.5600 0.6700 0.8000 0.9500
Free Cash Flow - - - - -
FCF margin - - - - -
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - -
Announcement Date 22/04/22 07/04/23 25/04/24 - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023 2024 2025
Net Debt - - - - -
Net Cash position - - - - -
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow - - - - -
ROE (net income / shareholders' equity) - 19.4% 20.5% 19.3% 19.5%
ROA (Net income/ Total Assets) - 12.2% - 10.5% 11%
Assets 1 - 1,072 - 1,781 2,018
Book Value Per Share 2 - 3.080 3.540 4.120 4.870
Cash Flow per Share - - - - -
Capex 1 - 66.6 54.8 198 188
Capex / Sales - 9.46% 6.53% 20.48% 16.76%
Announcement Date 22/04/22 07/04/23 25/04/24 - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
13.14 CNY
Average target price
18 CNY
Spread / Average Target
+36.99%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ANHUI SUNHERE PHARMACEUTICAL EXCIPIENTS CO.,LTD. Stock Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.
-7.72% 423M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+35.01% 709B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+30.87% 595B
JOHNSON & JOHNSON Stock Johnson & Johnson
-2.60% 367B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.83% 334B
ABBVIE INC. Stock AbbVie Inc.
+5.69% 289B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.30% 239B
NOVARTIS AG Stock Novartis AG
+9.32% 211B
ROCHE HOLDING AG Stock Roche Holding AG
-3.23% 203B
AMGEN INC. Stock Amgen Inc.
+10.77% 171B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 300452 Stock
  4. Financials Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.